Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression

J Neuroimmunol. 2001 Jul 2;117(1-2):51-7. doi: 10.1016/s0165-5728(01)00325-3.

Abstract

Melatonin is hypothesized to play a role in neuroimmunomodulation. This study investigated the in vitro effects of melatonin (10(-12) - 10(-6) M) on human peripheral blood mononuclear cell (PBMC) proliferation and T helper type 1 and T helper type 2 (Th1/Th2) cytokine expression. In vitro doses of melatonin significantly increased PBMC proliferation (p<0.05) and decreased IL-10 production in culture supernatants (p<0.05). However, there was no effect of melatonin on the stimulated production of IFN-gamma or on the intracellular accumulation of the activation antigen CD69, IFN-gamma, or IL-10 as measured by flow cytometry. These data support the notion that physiologic doses of melatonin increase lymphocyte proliferation possibly due to decreases in production of the inhibitory cytokine IL-10.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Cytokines / biosynthesis*
  • Female
  • Humans
  • Lymphocyte Activation / drug effects*
  • Male
  • Melatonin / pharmacology*
  • Middle Aged
  • Th1 Cells / drug effects*
  • Th1 Cells / physiology
  • Th2 Cells / drug effects*
  • Th2 Cells / physiology

Substances

  • Cytokines
  • Melatonin